[Chronic diverticular diseases. Rifaximin reduces symptoms and complications].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004239:Diverticulitis, Colonic / Q000150:complications / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D055502:Secondary Prevention
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin